Displaying 1–10 of 39 news results
Feb 28, 2023
Ophthalmology visionary Mark S. Blumenkranz, MD, MMS, to join RD Fund’s Board.
Jan 6, 2023
The investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
Oct 13, 2022
On World Sight Day 2022, Retina International is presenting data from a report on its study into the Socio-economic Impact of late-stage age-related macular degeneration (AMD) in Bulgaria, Germany, and USA.
Sep 15, 2022
Proceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
Jul 29, 2022
A multi-institutional effort led by researchers at the School of Veterinary Medicine is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
Jul 21, 2022
RD Fund Board member and seasoned ophthalmology leader Adrienne Graves, PhD, appointed chair. Ophthalmology luminaries Jean Bennett, MD, PhD, Catherine Bowes Rickman, PhD, and José-Alain Sahel, MD, to join the board.
Jun 15, 2022
Funds to support advancement of two clinical trials through proof of concept: NPI-001 for retinitis pigmentosa in Usher syndrome and NPI-002 to slow cataract progression.
May 12, 2022
Biopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
Mar 3, 2022
Industry Veteran Brings Broad Ophthalmology Research & Development Expertise.
Jan 6, 2022
Investment in new portfolio company furthering genetic medicine approaches for individuals affected by retinal degenerative diseases.